Information alerting on drug drug interactions now augments PGx reports

According to the Centers for Disease Control, 29% of the US population takes 5 or more medications. Adverse drug events cause more than 1 million emergency department visits each year making this a major expense to the healthcare system.

Translational Software has partnered with First Databank to surface potential Drug-Drug interactions in conjunction with Drug-Gene interaction reports. The additional information can also be delivered through TSI’s MedsReview or API platforms.

Complete the contact form to learn more about adding Drug-Drug interaction warnings to your pharmacogenomic reports and opt-in to receive regular updates from Translational Software®.